p53 expression, K-ras gene mutation and microsatellite instability in gastric B-cell lymphomas

被引:5
|
作者
Hiyama, T
Tanaka, S
Masuda, H
Shima, H
Kose, K
Tuncel, H
Ito, M
Kitadai, Y
Sumii, M
Uemura, N
Yoshihara, M
Shimamoto, F
Haruma, K
Chayama, K
机构
[1] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima 7398521, Japan
[2] Hiroshima Univ Hosp, Dept Endoscopy, Higashihiroshima, Japan
[3] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan
[4] Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan
[5] Kure Kyosai Hosp, Dept Gastroenterol, Kure, Japan
[6] Kawasaki Med Sch, Div Gastroenterol, Kurashiki, Okayama, Japan
关键词
B-cell lymphoma; K-ras; microsatellite instability; p53; stomach;
D O I
10.1046/j.1440-1746.2003.03120.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Genetic mechanisms involved in the development of gastric B-cell lymphomas remain unclear. The aim of the present study was to clarify the roles of mutations of the p53 and K-ras genes, and microsatellite instability (MSI) in the development of gastric B-cell lymphomas. Methods: We investigated p53 immunoreactivity, mutations of the K-ras gene, and MSI in 27 gastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue type (MZBCL) and 24 diffuse large B-cell lymphomas (DLBCL). p53 immunoreactivity was examined using a monoclonal antibody, DO-7. Mutation of the K-ras gene was detected by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis. MSI was examined at five microsatellite loci with a microsatellite assay. Cases were classified as having high-frequency MSI (MSI-H) (greater than or equal to 2 loci showing instability), low-frequency MSI (MSI-L) (only one locus showing instability), or as microsatellite stable. Results: p53 immunoreactivity was detected in 1 of 16 (6%) MZBCL and 8 of 19 (42%) DLBCL. Frequency of p53 immunoreactivity in DLBCL was significantly higher than that in MZBCL (P = 0.018). MSI-H was detected only in 1 of 20 (5%) DLBCL. None of the cases examined showed mutation of the K-ras gene. Conclusions: These data suggest that mutations of the p53 gene may play an important role in the development of gastric DLBCL, and that mutations of the K-ras gene and MSI may be involved in little part of the development of gastric B-cell lymphomas. (C) 2003 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [41] p53 Expression is Decreased in Primary Breast Carcinomas with Microsatellite Instability
    Claudia Pizzi
    Luigi Panico
    Laura De Marchis
    Paolo Mastranzo
    Massimo Di Maio
    Cristina D'amico
    Gennaro Limite
    Guido Pettinato
    Sergio Cocozza
    Angelo Raffaele Bianco
    Alma Contegiacomo
    Breast Cancer Research and Treatment, 2002, 73 : 257 - 266
  • [42] Depth of infiltration of primary gastric B-cell lymphomas - Correlations with proliferation, apoptosis and expression of p53 and bcl-2
    Eidt, S
    Lorenzen, J
    Ortmann, M
    PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (09) : 925 - 930
  • [43] p53 expression is decreased in primary breast carcinomas with microsatellite instability
    Pizzi, C
    Panico, L
    De Marchis, L
    Mastranzo, P
    Di Maio, M
    D'amico, C
    Limite, G
    Pettinato, G
    Cocozza, S
    Bianco, AR
    Contegiacomo, A
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (03) : 257 - 266
  • [44] Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer
    Nyiraneza, Christine
    Jouret-Mourin, Anne
    Kartheuser, Alex
    Camby, Philippe
    Plomteux, Olivier
    Detry, Roger
    Dahan, Karin
    Sempoux, Christine
    HUMAN PATHOLOGY, 2011, 42 (12) : 1897 - 1910
  • [45] Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans
    Takahira, T
    Oda, Y
    Tamiya, S
    Yamamoto, H
    Kawaguchi, K
    Kobayashi, C
    Oda, S
    Iwamoto, Y
    Tsuneyoshi, M
    HUMAN PATHOLOGY, 2004, 35 (02) : 240 - 245
  • [46] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [47] Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection
    Liang, JT
    Cheng, YM
    Chang, KJ
    Chien, CT
    Hsu, HC
    HEPATO-GASTROENTEROLOGY, 1999, 46 (26) : 830 - 837
  • [48] Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines
    Loprevite, M
    Varesco, L
    Favoni, R
    Ferrara, GB
    Moro, F
    Ottaggio, L
    Fronza, G
    Campomenosi, P
    Abbondandolo, A
    Cutrona, G
    Roncella, S
    Albini, A
    Aluigi, MG
    Pozzi, S
    Pera, C
    Biticchi, R
    Gismondi, V
    Grossi, F
    Pennucci, MC
    Ardizzoni, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (06) : 1203 - 1208
  • [49] Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma
    Hermanová, M
    Lukás, Z
    Kroupová, I
    Kleibl, Z
    Novotny, J
    Nenutil, R
    Pazourková, M
    Brázdil, J
    Kren, L
    Díte, P
    NEOPLASMA, 2003, 50 (05) : 319 - 325
  • [50] Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors
    Kaino, M
    Kondoh, S
    Okita, S
    Hatano, S
    Shiraishi, K
    Kaino, S
    Okita, K
    PANCREAS, 1999, 18 (03) : 294 - 299